Merck’s CEO, Robert Davis, noted on an October conference call that the situation was unlikely to be resolved by the fourth quarter. The headwinds continue to play out despite Gardasil just last ...

In 2013 the American artist, Noah Davis used a legacy left him by his father to create a museum of contemporary art in ...

In addition, in 2024 Merck received over 25 approvals in other major regions of the world. Robert M. Davis, chairman and chief executive officer, Merck said in a statement, “We delivered strong ...

Management expects mid-to-high single-digit growth in Merck's total business outside ... citing clinical data concerns. Rob Davis affirmed confidence, stating January trends align with ...

Tjitska Theadora “Thea” Kranzo, 56, of Jamestown, peacefully passed on surrounded by her beloved family and dogs at home on Friday, February 7, 2025. She was born to Gonnie Konneman Siekmans and the ...

Anthony Davis has already experienced a level of highs and lows during his first week as a member of the Dallas Mavericks. Davis made his debut in Dallas at the American Airlines Center on ...

Merck CEO Robert Davis said on an earnings call that Gardasil inventory in China "remains elevated at above normal levels," noting that demand for the shot has not recovered to the level the ...

Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the “real culprit” for Merck shares remaining under ...

Merck (MRK) reported fourth quarter and full-year earnings Tuesday, in line with Wall Street estimates. The bad news: Its stock was down more than 10% in early trading, largely because of weaker ...

Davis, who was recently traded from the Lakers to the Mavericks, stars in a delightful new commercial for CeraVe Ron Jenkins/Getty Anthony Davis knows how to leave people wanting more. Davis, 31 ...

Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at Leerink Partners believe that Merck’s Winrevair “should have ...